To explore the mechanism of IGF2BP3 in cervical cancer cells, we overexpressed or silenced IGF2BP3 in cervical cancer cells, and WB experiments were used to verify the expression of EMT biomarker proteins after transfection (Figure 4A). This evidence concerns the gene IGF2BP3 and cervical carcinoma.